# NOREPINEPHRINE BITARTRATE
> **ANDA217575** · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2023-09-15
## Drug
- **FDA Application Number:** ANDA217575
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NOREPINEPHRINE BITARTRATE
- **Generic name:** NOREPINEPHRINE BITARTRATE
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CAPLIN
- **Manufacturer:** NorthStar Rx LLC
- **First approval:** 2023-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217575)
---
*AI Analytics · CC0 1.0*